Bicycle Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BCYC and other ETFs, options, and stocks.About BCYC
Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications.
CEOKevin Lee
CEOKevin Lee
Employees305
Employees305
HeadquartersCambridge, Cambridgeshire
HeadquartersCambridge, Cambridgeshire
Founded2009
Founded2009
Employees305
Employees305
BCYC Key Statistics
Market cap565.61M
Market cap565.61M
Price-Earnings ratio-2.85
Price-Earnings ratio-2.85
Dividend yield—
Dividend yield—
Average volume364.52K
Average volume364.52K
High today$8.58
High today$8.58
Low today$8.15
Low today$8.15
Open price$8.40
Open price$8.40
Volume131.57K
Volume131.57K
52 Week high$28.67
52 Week high$28.67
52 Week low$6.10
52 Week low$6.10
BCYC News
TipRanks 18h
Bicycle Therapeutics Reveals Promising Imaging Data at AACRBicycle Therapeutics ( (BCYC) ) has issued an update. On April 29, 2025, Bicycle Therapeutics announced additional human radiopharmaceutical imaging data for M...
Analyst ratings
79%
of 14 ratingsBuy
78.6%
Hold
21.4%
Sell
0%